Vesalius Longevity Labs Secures $25 Million To Expand Global Market Presence
Building Size
—
Asset Type
—
Closing
Nov 16, 2026
About this deal
AI
Vesalius Longevity Labs raised $25 million to enhance its longevity and regenerative health platform, which focuses on peptides, biologics, and preventative healthcare. The capital will assist in expanding its sales team, entering new global markets, and meeting the demand for safe, regulated access to longevity therapies.
Summary of transaction details:
- Deal Type: Investment
- Transaction Amount: $25,000,000
- Company Headquarters: Scottsdale, Arizona & Vancouver, British Columbia
- Notable Investors: David Adelman, Harvey Spevak, Kevin Mayer, David Blitzer, Dana White, Gary Brecka, Brigham Buhler
Founded by James McRoberts, Vesalius Longevity Labs operates a proprietary ecosystem that connects healthcare providers with compliant pharmacies, enabling access to therapies, education, and partnerships. The company plans to manufacture its own Peptual® “Made-in-the-USA” peptide APIs for distribution to compounding pharmacies both domestically and internationally.
Players
Market CRE Market Snapshot
Boundary boundary · CRE · Raise transactions
Loading comparables…
Deal FAQ
Browse this market sales on Traded.
Purchase Price
Annual NOI
Loan Amount
Interest Rate (%)
Loan Term (yrs)
Down Payment (%)
Cap Rate
5.80%
Cash-on-Cash
-1.66%
Monthly Payment
$14,164
Annual Debt Svc
$169,964
Annual Cash Flow
$-11,334
DSCR
0.93